Today marks my last day as a nephrologist and #IMG in the United States of America. I've learned the hard way that life is too short and that my happiness lies within my family's happiness. So, I'm returning permanently to my home country, Egypt. (🧵 1)

There is nothing wrong with being an Achiever. The key is to have a healthy relationship with achievement: Progress > Perfection Humility > Ego Consistency > Intensity Self-care > Self-sacrifice Collaboration > Competition Every. Single. Time.

🩺 Join us for the Toronto PKD Scientific Day on November 7, 2026! An opportunity to explore advances in polycystic kidney disease research and clinical care. In-person or virtual! 📄 Program & registration: wombat-d6770h.my.canva.site/… #ADPKD #PKD #Nephrology #ENDPKD

From stone removal to disease management: do the 2026 EAU Guidelines call for a new Urology–Nephrology partnership? doi.org/10.1093/ndt/gfag241

How do you manage immunosuppression in dialysis-dependent glomerulonephritis? 🛑STOP: When risks outweigh benefits (e.g., infections, malignancy, fatal drug interactions). Primum non nocere. ⤵️TAPER: When renal recovery is unlikely (e.g., extensive IF/TA or advanced irreversible Anti-GBM injury), or to prevent rebound complications (e.g., prolonged corticosteroid therapy). ✅CONTINUE: If renal recovery remains possible, extrarenal disease is active, or to reduce post-transplant recurrence risk in selected active diseases. Special thanks to 18th ADC Conference Leadership for the Kind Invitation.

Meet our distinguished guests @mediterrakidsoc @ERAkidney @ESNT_Egy @AfricanAFRAN @WomenNephAfrica

A very important question: When do you continue, taper or stop immunosuppression for glomerulonephritis when transitioning to hemodialysis? Looking forward to an engaging discussion tomorrow in the 18th Annual Dialysis Conference in Cairo.

Cardiovascular–kidney–metabolic syndrome and cancer nature.com/articles/s41581-0… @NatRevNeph @kdjhaveri @Northwell_Med

I was trying to read and understand ICI-associated AKI and realised I couldn’t even remember (and legit don’t even know) all the immune checkpoint inhibitors or how exactly they work as anti-tumour therapies. 😅 So, let’s go back to the basics! What are ICIs? How do they help our immune system fight cancer? And what happens when that same activation affects the kidneys? Over the next week, let’s unpack this together. I’ve taken up stuff from various sources and my own understanding of things, and will cite some of them ! @NatRevNeph @DavidLeaf9 @PepaSolerR @arvindcanchi @drshyambansal @isn_india @rc_oncneph @HerrmannMd @SabineKaram6 @DineshaSNep @CristinaDeReins @brian_rifkin @kidneymo @kidney_boy @BasuNephro

A great discussion with Dr. Ali Mehdi from @CleClinicKidney on the evolving IgA nephropathy treatment landscape. Despite the advances, many questions remain! @glomconarabia @GlomCon

Now off to April/BAFF targeting therapies in IgAN by Dr. Ali Mehdi @CleClinicKidney @GlomCon @glomconarabia

A brilliant @glomconarabia session on IgA Nephropathy by the amazing Dr. Ali Mehdi @CleClinicKidney @GlomCon

In 20 mins

Happy Friday ☀️🌊🛥️

We are excited to host another session in the GlomCon Arabia Seminar Series tomorrow Friday, October 9, 2026 This session will feature an expert presentation by Dr. Ali Mehdi “IgA Nephropathy: Where We Are and Where We Are Going” Meeting details: glomcon.zoom.us Meeting ID: 884 4208 1901 Passcode: 100499 @GlomCon @glomconarabia #NephrologyEducation #MedicalCommunity #GlobalMedicine @CleClinicKidney

Now open access in @NDTsocial How to treat “FSGS”? A conceptual framework 🧐This concept helps navigating “FSGS”at kidney biopsy by respecting its need for CKD care + the diagnostic workup needed to identify the correct Tx for causative diseases. ▶️academic.oup.com/ndt/article…

RT @Na2ef: Do not miss this coming Friday

See below for some highlights for the upcoming pre course @ASNKidney #kidneyweek2026 on @onconephsociety

Rethinking Proteinuria During Vascular Endothelial Growth Factor-Axis Therapy: Toward a Biopsy-Informed Approach - Kidney International Reports kireports.org/article/S2468-…